These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33609973)

  • 1. Impact of high-risk features for stage II adenocarcinoma of the appendix.
    Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
    Cancer Treat Res Commun; 2021; 27():100329. PubMed ID: 33609973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
    Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
    Surg Oncol; 2021 Mar; 36():120-129. PubMed ID: 33360118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal Adenocarcinoma.
    AlMasri SS; Paniccia A; Hammad AY; Pai RK; Bahary N; Zureikat AH; Medich DS; Celebrezze JP; Choudry HA; Nassour I
    J Gastrointest Surg; 2022 Jan; 26(1):171-180. PubMed ID: 34291365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
    Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
    Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
    Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
    Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node positivity and association with long-term survival for different histologies of appendiceal cancer.
    Webb C; Chang YH; Pockaj BA; Gray RJ; Stucky CC; Wasif N
    J Surg Oncol; 2021 Jul; 124(1):88-96. PubMed ID: 33902156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenocarcinoma of the appendix in Iceland 1990-2009. A population based study].
    Vidarsdottir H; Jónasson JG; Möller PH
    Laeknabladid; 2011 Oct; 97(10):537-42. PubMed ID: 21998147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
    Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma.
    Shannon AB; Goldberg D; Song Y; Paulson EC; Roses RE; Fraker DL; Kelz RR; Miura J; Karakousis GC
    J Surg Oncol; 2020 Sep; 122(3):399-406. PubMed ID: 32346885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix.
    Fields AC; Lu P; Enzinger A; Goldberg J; Irani J; Bleday R; Nash G; Melnitchouk N
    J Surg Oncol; 2019 Dec; 120(7):1096-1101. PubMed ID: 31592538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Small Bowel Adenocarcinoma.
    Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
    Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
    Enomoto LM; Choudry MH; Bartlett DL; Totin L; Mann GN; Skitzki JJ; Perry KC; Votanopoulos KI; Levine EA; Shen P
    Ann Surg Oncol; 2020 Jan; 27(1):107-114. PubMed ID: 31368017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.